About ARK Genomic Revolution ETF
Actively managed ETF from ARK Invest targeting genomics, CRISPR, and biotech innovation companies. Minimal dividend, high volatility for an ETF, concentrated in speculative biotech holdings. Elevated CSP premiums but returns hinge on biotech sentiment and active management decisions.